Complementary synergy is obtained with the combination of API supply, drug R&D and manufacturing segments of parent company Hisun Pharmaceuticals and sales segment of Hanhui Pharma. While Hanhui pharma seeks to cooperate with its partners in CSO or other BD models, Hisun Pharmaceuticals may also provide CRO, CMO and CDMO services. Hanhui Pharma has developed a platform for whole-value-chain cooperation of research, manufacturing and marketing with the support of the parent company.